Search | WHO COVID-19 Research Database

1.

Estimating real-world outcomes under a rapidly evolving treatment paradigm: Dexamethasone and inpatient mortality among us hospitalized COVID-19 patients

Garry, E. M.; Easthausen, I.; Vititoe, S.; Weckstein, A.; Chakravarty, A.; Lasky, T.; Bradley, M.; Perez-Vilar, S.; Rivera, D.; Quinto, K.; Zhang, D.; Zhao, Y. Q.; Rajpal, A.; Baglivo, A.; Rassen, J.; Leonard, S.; Gatto, N..

Pharmacoepidemiology and Drug Safety ; 31:24-25, 2022.

Article in English | Web of Science | ID: covidwho-2083645

2.

Systemic corticosteroids for COVID-19 in US outpatient settings

Bradley, M.; Graham, D.; Eworuke, E.; Lee, H.; Akhtar, S.; Lyu, H.; Naik, K.; Chillarige, Y.; Cunningham, F.; Dong, D.; Zhang, R. P.; Cocoros, N. M.; Cosgrove, A.; Martinez, A.; Maro, J.; Weckstein, A.; Baglivo, A.; Vititoe, S.; Garry, E. M.; Gatto, N.; Kelman, J.; Perez-Vilar, S..

Pharmacoepidemiology and Drug Safety ; 31:92-92, 2022.

Article in English | Web of Science | ID: covidwho-2083456

3.

Temporal trends in medication utilization among hospitalized COVID-19 patients

Weckstein, A. R.; Vititoe, S.; Rivera, D. R.; Bradley, M. C.; Perez-Vilar, S.; Leonard, S.; Garry, E. M.; Gatto, N. M.; Rassen, J. A..

Pharmacoepidemiology and Drug Safety ; 30:351-352, 2021.

Article in English | Web of Science | ID: covidwho-1381788

4.

Examining the evolving pandemic: Trends in COVID-19 severity for hospitalized COVID-19 patients over time

Vititoe, S.; Weckstein, A. R.; Chakravarty, A.; Bradley, M. C.; Lasky, T.; Gatto, N. M.; Garry, E. M..

Pharmacoepidemiology and Drug Safety ; 30:224-224, 2021.

Article in English | Web of Science | ID: covidwho-1381786

5.

Temporal changes in the baseline patient characteristics of COVID-19 patients

Okobi, M.; Prince, P.; Roe, L. M.; Rivera, D. R.; Quinto, K.; Leonard, S.; Garry, E. M.; Wang, M.; Gatto, N. M..

Pharmacoepidemiology and Drug Safety ; 30:351-351, 2021.

Article in English | Web of Science | ID: covidwho-1381733

6.

COVID-19 confidential: Enabling trust in COVID-19 research with fit for purpose real-world data

Gatto, N. M.; Franklin, J.; Garry, E. M.; Martin, D.; Chakravarty, A.; Rassen, J. A..

Pharmacoepidemiology and Drug Safety ; 30:6-6, 2021.

Article in English | Web of Science | ID: covidwho-1381674

7.

Use of an EHR to inform a claims-based algorithm to categorize inpatient COVID-19 severity

Garry, E. M.; Weckstein, A. R.; Quinto, K.; Lasky, T.; Chakravarty, A.; Leonard, S.; Vititoe, S.; Rassen, J. A.; Gatto, N. M..

Pharmacoepidemiology and Drug Safety ; 30:93-93, 2021.

Article in English | Web of Science | ID: covidwho-1381673

8.

Categorization of COVID-19 severity to determine mortality risk

Garry, E. M.; Weckstein, A. R.; Quinto, K.; Bradley, M. C.; Lasky, T.; Leonard, S.; Vititoe, S.; Gatto, N. M..

Pharmacoepidemiology and Drug Safety ; 30:91-91, 2021.

Article in English | Web of Science | ID: covidwho-1381672

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL